In compliance with the relevant provisions of Regulation 30 read with Clause 7 of Part A, Para A of Schedule III, along with such other applicable provisions of the SEBI (LODR) Regulation, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare has appointed four new directors to its Board with effect from January 9, 2026, following the NCLT's approval of a resolution plan on December 18, 2025, under the Insolvency and Bankruptcy Code. Mr. Pradeep Kumar Jain, the Successful Resolution Applicant, and Mr. Rajesh Jain (his relative) have been appointed as Promoter and Non-Executive Directors. Mr. Manish Goswami and Mr. Anjani Misra have been appointed as Independent Non-Executive Directors for a five-year term. The Interim Board's powers are currently suspended and are being exercised by the Resolution Plan Implementation Committee chaired by former Resolution Professional Roshen Chordiya. Full board powers will be restored once the Resolution Plan Closure Date is reached.
This marks a fresh start for the company post-insolvency, with a new promoter group (Jain family, linked to Ananta Medicare) taking control of the Board. Shareholders should expect strategic restructuring and a potential shift in business direction as the new management settles in.